Literature DB >> 17279402

CT of the chest in the evaluation of idiopathic pulmonary arterial hypertension in children.

Gulraiz Chaudry1, Cathy MacDonald, Ian Adatia, Munire Gundogan, David Manson.   

Abstract

BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease in children. By definition it is a diagnosis of exclusion, and CT of the chest is primarily performed to exclude other causes. Previous studies have defined CT features suggestive of the diagnosis of IPAH, but these have all been limited to the adult population.
OBJECTIVE: Contrast-enhanced chest CT and high-resolution CT findings in IPAH were evaluated in an attempt to define features consistently seen in children with this condition.
MATERIALS AND METHODS: The chest CT scans performed at initial presentation were reviewed in 17 children with echocardiographic or angiographic evidence of IPAH. RESULT: There were nine boys and eight girls, ranging in age from 1 month to 17 years. The extrapulmonary findings included cardiomegaly with right-sided cardiac enlargement, which was seen in 13 children. The central pulmonary arteries were enlarged in 15 children, with peripheral enlargement in two. In six children this resulted in bronchial compression. In addition, mediastinal and hilar lymphadenopathy was noted in three children. Prominent intrapulmonary features included a peripheral vasculopathy, with enlarged tortuous vessels, seen in eight children. Ill-defined ground-glass centrilobular opacities were also noted in eight children, representing the most common parenchymal abnormality. Other findings included septal lines in five, diffuse ground-glass opacification in four and focal hyperlucent zones in three. Mosaic attenuation was seen in one child.
CONCLUSION: A variety of imaging findings are identified in IPAH. Features particularly consistent with the diagnosis include peripheral vasculopathy and centrilobular opacities in the setting of cardiomegaly and central pulmonary arterial enlargement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279402     DOI: 10.1007/s00247-007-0410-8

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  18 in total

Review 1.  CT imaging of peripheral pulmonary vessel disease.

Authors:  Arnaud Resten; Sophie Maitre; Dominique Musset
Journal:  Eur Radiol       Date:  2005-05-20       Impact factor: 5.315

2.  Mosaic pattern of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes.

Authors:  A D Sherrick; S J Swensen; T E Hartman
Journal:  AJR Am J Roentgenol       Date:  1997-07       Impact factor: 3.959

Review 3.  Thoracic manifestations of sickle cell disease.

Authors:  C S Leong; P Stark
Journal:  J Thorac Imaging       Date:  1998-04       Impact factor: 3.000

4.  Pericardial thickening or effusion in patients with pulmonary artery hypertension: a CT study.

Authors:  M C Baque-Juston; A U Wells; D M Hansell
Journal:  AJR Am J Roentgenol       Date:  1999-02       Impact factor: 3.959

5.  Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical College of Wisconsin Lung Transplant Group.

Authors:  R T Tan; R Kuzo; L R Goodman; R Siegel; G B Haasler; K W Presberg
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

Review 6.  Recent advances in pulmonary vascular disease.

Authors:  Ian Adatia
Journal:  Curr Opin Pediatr       Date:  2002-06       Impact factor: 2.856

7.  Vasodilator therapy for primary pulmonary hypertension in children.

Authors:  R J Barst; G Maislin; A P Fishman
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

8.  Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension.

Authors:  Joseph K Perloff; Eric M Hart; S Melanie Greaves; Pamela D Miner; John S Child
Journal:  Am J Cardiol       Date:  2003-07-15       Impact factor: 2.778

9.  Chronic pulmonary thromboembolism: detection of regional hypoperfusion with CT.

Authors:  M A King; C J Bergin; D W Yeung; E E Belezzouli; L K Olson; W L Ashburn; W R Auger; K M Moser
Journal:  Radiology       Date:  1994-05       Impact factor: 11.105

Review 10.  Pulmonary arterial hypertension in children.

Authors:  Erika Berman Rosenzweig; Allison C Widlitz; Robyn J Barst
Journal:  Pediatr Pulmonol       Date:  2004-07
View more
  5 in total

1.  Diameters of normal thoracic vascular structures in pediatric patients.

Authors:  Hatice Ozturkmen Akay; Cihan Akgul Ozmen; Aylin Hasanefendioğlu Bayrak; Senem Senturk; Selahattin Katar; Hasan Nazaroglu; Mustafa Taskesen
Journal:  Surg Radiol Anat       Date:  2009-06-25       Impact factor: 1.246

2.  Idiopathic, heritable and veno-occlusive pulmonary arterial hypertension in childhood: computed tomography angiography features in the initial assessment of the disease.

Authors:  Laureline Berteloot; Maïa Proisy; Jean-Philippe Jais; Marilyne Lévy; Nathalie Boddaert; Damien Bonnet; Francesca Raimondi
Journal:  Pediatr Radiol       Date:  2019-01-16

3.  Pulmonary arterial hypertension in children: diagnosis using ratio of main pulmonary artery to ascending aorta diameter as determined by multi-detector computed tomography.

Authors:  Pablo Caro-Domínguez; Gregory Compton; Tilman Humpl; David E Manson
Journal:  Pediatr Radiol       Date:  2016-05-19

4.  Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Authors:  D Dunbar Ivy; Aimee K Doran; Kelly J Smith; George B Mallory; Maurice Beghetti; Robyn J Barst; Daniela Brady; Yuk Law; Donna Parker; Lori Claussen; Steven H Abman
Journal:  J Am Coll Cardiol       Date:  2008-01-15       Impact factor: 24.094

5.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.